Clinical Trials Browser

Phase 3 × Completed × Vomiting × Clear all

NCT00343460 2026-03-02

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Phase 3 Completed

1,428 enrolled 21 charts

Nausea, Vomiting

NCT06007586 2025-12-04

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Phase 3 Completed

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vomiting, Endometrial Neoplasms

NCT03984214 2025-04-10

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms, Vomiting

NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

401 enrolled 14 charts

Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

NCT02939287 2024-10-22

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Phase 3 Completed

52 enrolled 11 charts

Nausea, Vomiting, Neoplasms, Plasma Cell

NCT05564286 2024-02-06

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Phase 3 Completed

GynecologicHead & Neck

Uterine Cervical Neoplasms, Nasopharyngeal Neoplasms, Vomiting

NCT03674294 2023-02-08

CINV

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

NCT04232423 2022-01-21

OLN-EME

Phase 3 Completed

Vomiting

NCT01363479 2021-09-22

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Phase 3 Completed

743 enrolled 10 charts

Vomiting

NCT02909478 2021-07-29

Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer

Phase 3 Completed

Gastrointestinal

Vomiting, Colorectal Neoplasms

NCT01536392 2021-06-11

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

Phase 3 Completed

76 enrolled 8 charts

Uterine Cervical Neoplasms, Nausea, Vomiting

NCT01661335 2021-03-23

Efficacy of Aprepitant (Emend®) in Children

Phase 3 Completed

Nausea, Neoplasms, Vomiting

NCT00553059 2020-10-09

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

Phase 3 Completed

62 enrolled 15 charts

Nausea, Vomiting

NCT03403712 2020-06-01

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Phase 3 Completed

404 enrolled 19 charts

Vomiting

NCT00003685 2020-04-03

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Phase 3 Completed

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms, Nausea, Pain, Vomiting

NCT00016380 2020-04-03

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Phase 3 Completed

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Nausea, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Seminoma

NCT00046865 2018-11-14

Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer

Phase 3 Completed

Breast Neoplasms, Nausea, Vomiting

NCT02557035 2018-06-20

An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting

Phase 3 Completed

441 enrolled 20 charts

Vomiting

NCT00601172 2018-01-17

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Phase 3 Completed

710 enrolled 29 charts

Gastrointestinal

Nausea, Vomiting, Colorectal Neoplasms

NCT00431236 2017-08-22

A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase 3 Completed

Nausea, Vomiting

NCT02028832 2017-05-08

PIM

Phase 3 Completed

Anxiety Disorders, Nausea, Neoplasms, Pain, Vomiting

NCT00092196 2017-05-05

Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

Phase 3 Completed

Breast Neoplasms, Nausea, Vomiting

NCT02203253 2016-08-24

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

Phase 3 Completed

Neoplasms, Vomiting

NCT00006348 2016-07-06

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Phase 3 Completed

DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellSarcoma

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Nausea, Polycythemia Vera, Precancerous Conditions, Recurrence, Sezary Syndrome, Thrombocythemia, Essential, Vomiting, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis, Intraocular Lymphoma

NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

Phase 3 Completed

1,021 enrolled 10 charts

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00020657 2015-10-15

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Phase 3 Completed

Nausea, Vomiting

NCT01074697 2015-04-24

GAND-emesis

Phase 3 Completed

Genital Neoplasms, Female, Nausea, Vomiting

NCT01339260 2014-11-26

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Phase 3 Completed

1,455 enrolled 11 charts

Vomiting

NCT00978185 2013-08-26

Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy

Phase 3 Completed

Anxiety Disorders, Nausea, Vomiting

NCT00978549 2013-08-07

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

Phase 3 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Nausea, Pain, Stomach Neoplasms, Vomiting

NCT00003213 2012-07-11

Drugs to Reduce the Side Effects of Chemotherapy

Phase 3 Completed

Nausea, Vomiting

NCT00152867 2012-06-28

Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy

Phase 3 Completed

Nausea, Neoplasms, Vomiting

NCT00971399 2011-02-28

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Phase 3 Completed

Vomiting

NCT00409071 2010-02-05

Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.

Phase 3 Completed

Breast Neoplasms, Nausea, Vomiting

NCT00268125 2009-03-18

Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.

Phase 3 Completed

Breast Neoplasms, Nausea, Vomiting